from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3118/sseC1

LFCtreatmentdescriptionclass of inhibitor

-0.060

Amikacinug/mL Amikacintranslation

-0.478

Cap5-10ug/mL Capreomycintranslation

-0.420

Rox10-50 ug/mL Roxithromycintranslation

0.988

SM2-5 ug/mL Streptomycintranslation

1.343

Tet5-10 ug/mL Tetracyclinetranslation

-1.278

Rif0.2-5ug/mL Rifampicintranscription

-0.936

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.364

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.193

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.397

CPZ10-50 ug/mL Chlorpromazinerespiration

1.681

Clofazimine10-13 ug/mL Clofaziminerespiration

0.846

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.308

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.245

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.557

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.153

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.061

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.412

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.893

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.155

KCN5-20 ug/mL Potassium cyaniderespiration

1.877

NaN30.2-2 mM Sodium aziderespiration

-0.564

Nigericin50 uM Nigericinrespiration

-0.167

TRC10-150 ug/mL Triclosanrespiration

0.046

TRZ10-25 ug/mL Thioridazinerespiration

-0.446

Valinomycin0.5-10 uM Valinomycinrespiration

3.657

ZnSO42 mM ZnSO4respiration

-0.128

menadione6-10 ug/mL Menadionerespiration

-0.779

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.310

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.330

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.357

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.445

NRP_1Non-replicating persistence stage 1dosRassociated

-0.119

Amp0.2mg/mL AmpicillincellWall

0.190

Cephalexin20-100 ug/mL CephalexincellWall

0.098

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.313

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.286

EMB10-20 ug/mL EthambutolcellWall

0.648

Eta12-40 ug/mL EthionamidecellWall

0.997

INH0.2-0.4 ug/mL IsoniazidcellWall

0.185

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.755

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.298

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.865

BZA0.12 mg/mL BenzamidearomaticAmides

-1.092

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.370

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.155

H2O24 mM hydrogen peroxideDNAdamaging

-0.875

Levo10 ug/mL LevofloxacinDNAdamaging

0.188

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.299

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.111

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.019

UVUV-irradiationDNAdamaging

0.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.011

Antimycin12.5-50 ug/mL Antimycin A?

0.166

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.267

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.319

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.287

PA8240.2-2 ug/mL PA-824?

1.062

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.663

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.365

Verapamil50 uM Verapamil?

-0.140

mercaptoethanol2 mM 2-Mercaptoethanol?

0.543

methoxatin10-20 ug/mL Methoxatin?